It refers to a kind of pharmacodynamic synthesis, including: (a) lakinimoud sodio with a dose of 0.5-1.0 mg / day； (b) mofetil fungus with a dose of 1-3 mg / day； (c) a kind of sterol, such as methylprednisone, prednisone and prednisone； (d) in addition, it also includes the application of various enzyme inhibitors to make angiococcus become the blocker of the receiver. Angiogenesis, anti recommender, stereoscopic, cyclophosphamide, etc. It's a treatment for lupus This treatment reduced protein content, improved the indicators of the British Isles Lupus Assessment Panel, and reduced the ratio of protein to creatinina.SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE: (A) LAQUINIMOD SODIO A UNA DOSIS DE 0.5 A 1.0 MG/DIA； (B) MICOFENOLATO MOFETIL A UNA DOSIS DE 1 A 3 MG/DIA； (C) UN ESTEROIDE TAL COMO METILPREDNISOLONA, PREDNISOLONA Y PREDNISONA； (D) ADEMAS LA ADMINISTRACION DE INHIBIDORES DE ENZIMAS QUE CONVIERTEN LA ANGIOTENSINA, BLOQUEADORES DEL RECEPTOR DE ANGIOTENSINA, ANTIPALUDICOS, ESTATINAS, CICLOFOSFAMIDA, ENTRE OTROS. REFERIDO A UN TRATAMIENTO CONTRA EL LUPUS NEFRITIS ACTIVO. DICHO TRATAMIENTO REDUCE LA PROTEINURIA, MEJORA EL INDICE DEL GRUPO DE EVALUACION DE LUPUS DE LAS ISLAS BRITANICAS (BILAG) Y REDUCE LA RELACION DE PROTEINA A CREATININA.
